- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-Q Quarterly report
- 10.1 Exclusive License Agreement, Dated March 15, 1995 - Hospital for Sick Children
- 10.2 Exclusive License Agreement, Dated January 6, 1995 - Endorecherche
- 10.3 Exclusive License Agreement, Dated March 13, 1996 - Trustees of University of Pa
- 10.4 License and Collaboration Agreement, Dated November 19, 2003
- 10.5 Myriad Genetics, Inc. Management Performance Program
- 10.6 Myriad Genetics, Inc. Non-employee Director Compensation Policy
- 10.7 Form of Incentive Stock Option Agreement
- 10.8 Form of Non-qualified Stock Option Agreement
- 10.9 Form of Incentive Stock Option Agreement
- 10.10 Form of Non-qualified Stock Option Agreement
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32.1 Certifications Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
Exhibit 32.1
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report on Form 10-Q for the quarter ended September 30, 2007 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 1, 2007 | Date: November 1, 2007 | |||||||
By: | /s/ Peter D. Meldrum | By: | /s/ Jay M. Moyes | |||||
Peter D. Meldrum | Jay M. Moyes | |||||||
President and Chief Executive Officer | Chief Financial Officer |
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.